139 related articles for article (PubMed ID: 8819504)
21. ZM241385 is an antagonist of the facilitatory responses produced by the A2A adenosine receptor agonists CGS21680 and HENECA in the rat hippocampus.
Cunha RA; Constantino MD; Ribeiro JA
Br J Pharmacol; 1997 Dec; 122(7):1279-84. PubMed ID: 9421273
[TBL] [Abstract][Full Text] [Related]
22. In vivo labelling of the adenosine A2A receptor in mouse brain using the selective antagonist [3H]SCH 58261.
El Yacoubi M; Ledent C; Parmentier M; Ongini E; Costentin J; Vaugeois JM
Eur J Neurosci; 2001 Nov; 14(9):1567-70. PubMed ID: 11722618
[TBL] [Abstract][Full Text] [Related]
23. A carboxyl-terminally truncated mutant and nonglycosylated A2a adenosine receptors retain ligand binding.
Piersen CE; True CD; Wells JN
Mol Pharmacol; 1994 May; 45(5):861-70. PubMed ID: 8190103
[TBL] [Abstract][Full Text] [Related]
24. Modulation of A2A adenosine receptor(s) by K+(ATP) channels in bovine brain striatal membranes.
Olanrewaju HA; Marala RB; Mustafa SJ
Cell Biol Int; 1999; 23(7):519-22. PubMed ID: 10728789
[TBL] [Abstract][Full Text] [Related]
25. 125I-APE binding to adenosine receptors in coronary artery: photoaffinity labeling with 125I-azidoAPE.
Hussain T; Linden J; Mustafa SJ
J Pharmacol Exp Ther; 1996 Jan; 276(1):284-8. PubMed ID: 8558444
[TBL] [Abstract][Full Text] [Related]
26. [3H]SCH 58261, a selective adenosine A2A receptor antagonist, is a useful ligand in autoradiographic studies.
Fredholm BB; Lindström K; Dionisotti S; Ongini E
J Neurochem; 1998 Mar; 70(3):1210-6. PubMed ID: 9489743
[TBL] [Abstract][Full Text] [Related]
27. Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as adenosine receptor antagonists. Influence of the N5 substituent on the affinity at the human A 3 and A 2B adenosine receptor subtypes: a molecular modeling investigation.
Pastorin G; Da Ros T; Spalluto G; Deflorian F; Moro S; Cacciari B; Baraldi PG; Gessi S; Varani K; Borea PA
J Med Chem; 2003 Sep; 46(20):4287-96. PubMed ID: 13678407
[TBL] [Abstract][Full Text] [Related]
28. Caffeine alters A2A adenosine receptors and their function in human platelets.
Varani K; Portaluppi F; Merighi S; Ongini E; Belardinelli L; Borea PA
Circulation; 1999 May; 99(19):2499-502. PubMed ID: 10330379
[TBL] [Abstract][Full Text] [Related]
29. Characterization of [3H]ZM 241385 binding in wild-type and adenosine A2A receptor knockout mice.
Kelly M; Bailey A; Ledent C; Kitchen I; Hourani S
Eur J Pharmacol; 2004 Nov; 504(1-2):55-9. PubMed ID: 15507221
[TBL] [Abstract][Full Text] [Related]
30. Novel 3-aralkyl-7-(amino-substituted)-1,2,3-triazolo[4,5-d]pyrimidines with high affinity toward A1 adenosine receptors.
Betti L; Biagi G; Giannaccini G; Giorgi I; Livi O; Lucacchini A; Manera C; Scartoni V
J Med Chem; 1998 Feb; 41(5):668-73. PubMed ID: 9513594
[TBL] [Abstract][Full Text] [Related]
31. GTP differentially affects antagonist radioligand binding to adenosine A(1) and A(2A) receptors in human brain.
Kull B; Svenningsson P; Hall H; Fredholm BB
Neuropharmacology; 2000 Sep; 39(12):2374-80. PubMed ID: 10974321
[TBL] [Abstract][Full Text] [Related]
32. Alpha 2-adrenergic receptors on canine platelet membranes characterized by [3H]-yohimbine binding.
O'Hara N; Yokota S; Kouchi Y; Ono H
Res Commun Chem Pathol Pharmacol; 1986 May; 52(2):179-94. PubMed ID: 3012728
[TBL] [Abstract][Full Text] [Related]
33. Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils.
Varani K; Gessi S; Merighi S; Iannotta V; Cattabriga E; Spisani S; Cadossi R; Borea PA
Br J Pharmacol; 2002 May; 136(1):57-66. PubMed ID: 11976268
[TBL] [Abstract][Full Text] [Related]
34. Distribution of adenosine receptors in the postmortem human brain: an extended autoradiographic study.
Svenningsson P; Hall H; Sedvall G; Fredholm BB
Synapse; 1997 Dec; 27(4):322-35. PubMed ID: 9372555
[TBL] [Abstract][Full Text] [Related]
35. [3H]A-317491, a novel high-affinity non-nucleotide antagonist that specifically labels human P2X2/3 and P2X3 receptors.
Jarvis MF; Bianchi B; Uchic JT; Cartmell J; Lee CH; Williams M; Faltynek C
J Pharmacol Exp Ther; 2004 Jul; 310(1):407-16. PubMed ID: 15024037
[TBL] [Abstract][Full Text] [Related]
36. Fish somatostatin sst3 receptor: comparison of radioligand and GTPgammaS binding, adenylate cyclase and phospholipase C activities reveals different agonist-dependent pharmacological signatures.
Siehler S; Nunn C; Zupanc GK; Hoyer D
Auton Autacoid Pharmacol; 2005 Jan; 25(1):1-16. PubMed ID: 15659149
[TBL] [Abstract][Full Text] [Related]
37. Adenosine A2A receptor agonists inhibit lipopolysaccharide-induced production of tumor necrosis factor-alpha by equine monocytes.
Sun WC; Moore JN; Hurley DJ; Vandenplas ML; Linden J; Cao Z; Murray TF
Vet Immunol Immunopathol; 2008 Jan; 121(1-2):91-100. PubMed ID: 17913243
[TBL] [Abstract][Full Text] [Related]
38. Binding characteristics of the adenosine A2 receptor ligand [3H]CGS 21680 to human platelet membranes.
Varani K; Borea PA; Guerra L; Dionisotti S; Zocchi C; Ongini E
Biochem Pharmacol; 1994 Oct; 48(8):1658-61. PubMed ID: 7980632
[TBL] [Abstract][Full Text] [Related]
39. Regulation of agonist binding to A2A adenosine receptors: effects of guanine nucleotides (GDP[S] and GTP[S]) and Mg2+ ion.
Mazzoni MR; Martini C; Lucacchini A
Biochim Biophys Acta; 1993 Dec; 1220(1):76-84. PubMed ID: 8268248
[TBL] [Abstract][Full Text] [Related]
40. Characterization of adenosine A2 receptors in bovine retinal membranes.
Blazynski C; McIntosh H
Exp Eye Res; 1993 May; 56(5):585-93. PubMed ID: 8500567
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
